RAD51 and neoplasm: Furthermore, a frequency distribution subdivision based on clinical parameters available for 34 tumors revealed that the reaction of RAD51-foci upon hyperthermia was not dependent on tumor grade, stage, recurrence or European Association of Urology risk stratification [43] (Fig 4D).